MedTrace Logo

Multimodal Postoperative Analgesia Following OSA Surgery

NCT04483427 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-09-28

No results posted yet for this study

Summary

Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser) for postoperative analgesia following multilevel OSA surgeries

Conditions

Interventions

COMBINATION_PRODUCT

Nalbuphine, ketorolac, accufuser

multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser)

Sponsors & Collaborators

  • Bahaa Mohammed Refaie

    lead OTHER

Principal Investigators

  • Bahaa M Refaie, MD · Lecturer of anesthesia and ICU sohag university

  • Mohammed E Ahmed, MD · Lecturer of ENT sohag university

  • A M Elhalwagy, MD · Consultant of pain medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-20
Primary Completion
2022-07-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04483427 on ClinicalTrials.gov